Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off

NCT00601978 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business decision brand strategy; no patients enrolled

Conditions

Parkinson's Disease

Interventions

DRUG: carbidopa/levodopa
DRUG: Carbidopa/Levodopa/Entacapone

Sponsor

Novartis Pharmaceuticals